Boenisch Sandra 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jul 1, 2021
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−25,000→ 0 totalExercise: $5.68Exp: 2025-10-02→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−35,000→ 0 totalExercise: $5.92Exp: 2027-05-12→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2021-06-29$3.28/sh+106,696$349,963→ 154,659 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−106,696→ 0 totalExercise: $3.28From: 2016-09-22Exp: 2026-09-22→ Common Stock (106,696 underlying) - Exercise/Conversion
Common Stock
2021-06-29$5.68/sh+25,000$142,000→ 47,963 total - Sale
Common Stock
2021-06-29$26.53/sh−166,696$4,422,445→ 22,963 total - Exercise/Conversion
Common Stock
2021-06-29$5.92/sh+35,000$207,200→ 189,659 total
Footnotes (2)
- [F1]The options subject to this grant vested quarterly over a three-year period commencing on December 31, 2015.
- [F2]The options subject to this grant vested quarterly over a three-year period commencing on June 30, 2017.